Fulgent Genetics' FID-007 Plus Cetuximab Shows 60% Response Rate And 7.2-Month Median PFS In Phase 2 Head And Neck Cancer Study With Favorable Safety Profile
Fulgent Genetics Inc FLGT
$17.90
▲ +1.30%
(+$0.23)
Open
$17.60
Prev Close
$17.67
Day Range
$17.40 – $17.99
52W Range
$13.46 – $31.04
Market Cap
$508.37M
Beta
0.92
EPS (TTM)
$-2.40
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2016-09-28 |
| Shares Out. | 28,400,000 |
| Website | fulgentgenetics.com/ ↗ |
| Phone | 13026587581 |
Fulgent Genetics Inc is a publicly traded company under the ticker symbol FLGT on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-05-01)